Mankind Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mankind Pharma Limited has filed a routine compliance certificate with the stock exchanges. The certificate, issued by KFin Technologies Limited (the company's Registrar and Share Transfer Agent), confirms that no requests for dematerialisation or rematerialisation of shares were received during the quarter from January 1, 2026 to March 31, 2026. This filing is a mandatory requirement under SEBI regulations for listed companies. The company Secretary Hitesh Kumar Jain signed and submitted the certificate on April 6, 2026.
This is a standard regulatory compliance filing with no direct impact on the company's financials or operations. It confirms normal share registry management and has no immediate implications for shareholders or stock price.